With India’s leadership and BRICS+ cooperation, agriculture can become not only a source of food, but a foundation for resilience, prosperi...

There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...

Quad foreign ministers met in Delhi focusing on practical cooperation. New initiatives target critical minerals, maritime surveillance, and...

Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...

As global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.

The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...

India is supplying drugs, vaccines, and medical devices to over 200 countries, with 11 countries recognizing Indian pharmacopoeia standards...

A WHO-led team reviewed India's vaccine regulatory system from September 16 to 20. The system was declared functional by meeting WHO's glob...

The government, which also provided details of the approval procedure, said the regulatory approval process of vaccines under the Drugs and...

The letter stated that on the directions of the prime minister, a high-powered Inter-Ministerial Committee for reforming the drug regulator...

Zydus had applied for emergency use authorisation (EUA) for its vaccine on July 1, but it is yet to be taken up by the subject expert commi...

MHRA said this is because authorised COVID-19 vaccines that  are modified in response to new variants will not need a brand new  approval o...

In the letter, Prakash Kumar Singh, the Director of Government and Regulatory Affairs at the Pune-based Serum Institute of India (SII) refe...

“India’s drug regulator is in touch with UK drug authorities on the approval progress of the AZ/Oxford vaccine trial,” Vinod Paul, head of ...

While at least five pharmaceutical companies of India are engaged in vaccine development, Serum Institute in Pune has been chosen for mass ...

India's Rs 19,000-crore vaccine industry accounts for exports worth 13 billion US dollars to 150 countries.

The World Health Organisation (WHO) has proposed a parallel review of vaccines manufactured by Indian companies, to be carried out by the C...